Difficulty: Medium
Average Score: 95%
Practice
A 15-year-old boy presents to clinic for follow-up for his tonic-clonic seizures. He reports that he has not had a seizure in the past 6 months. However, he has been more tired recently and is unsure why. A complete blood count is performed and shows megaloblastic anemia. The physician told the patient that this was most likely a side effect of his antiseizure medication. What is the most likely medication he was taking?
Correct answer
D
Rationale
The correct answer is D) Phenytoin. Phenytoin is known to cause megaloblastic anemia as a side effect due to its interference with folic acid metabolism. This drug can lead to folate deficiency, resulting in the development of megaloblastic anemia.
A) Carbamazepine is less likely to cause megaloblastic anemia compared to Phenytoin. It is known to cause hyponatremia and leukopenia as side effects.
B) Ethosuximide is primarily used for absence seizures and is not associated with megaloblastic anemia as a side effect.
C) Phenobarbital is more commonly associated with side effects like sedation, cognitive impairment, and physical dependence rather than megaloblastic anemia.
Educationally, understanding the side effects of antiseizure medications is crucial for healthcare providers to monitor and manage patients effectively. Recognizing potential adverse effects like megaloblastic anemia can lead to timely interventions and improved patient outcomes. It highlights the importance of regular monitoring and educating patients on possible side effects to promote medication adherence and safety.
A) Carbamazepine is less likely to cause megaloblastic anemia compared to Phenytoin. It is known to cause hyponatremia and leukopenia as side effects.
B) Ethosuximide is primarily used for absence seizures and is not associated with megaloblastic anemia as a side effect.
C) Phenobarbital is more commonly associated with side effects like sedation, cognitive impairment, and physical dependence rather than megaloblastic anemia.
Educationally, understanding the side effects of antiseizure medications is crucial for healthcare providers to monitor and manage patients effectively. Recognizing potential adverse effects like megaloblastic anemia can lead to timely interventions and improved patient outcomes. It highlights the importance of regular monitoring and educating patients on possible side effects to promote medication adherence and safety.